. . . . . . . . . . . . . . . . . . . . "a(SCHEM:Oxidopamine) -| (p(HGNC:SNCA) -| tscript(p(HGNC:TP53)))" . "p(HGNC:SNCA) -| tscript(p(HGNC:TP53))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "We demonstrate that the antiapoptotic phenotype displayed by alpha-synuclein can be fully reversed by the Parkinson's disease-associated dopamine derivative 6-hydroxydopamine. Thus, 6-hydroxydopamine fully abolishes the alpha-synuclein-mediated reduction of caspase 3 activity and reverses the associated decrease of p53 expression." . . "Selventa" . . . . "2014-07-03T14:31:55.760+02:00"^^ . . .